Profusa (PFSA) Share-based Compensation (2024 - 2026)

Profusa posted quarterly Share-based Compensation of $187000.0 for Q1 2026, up 3640.0% year-on-year from $5000.0 in Q1 2025, and up 150.0% on a QoQ basis from -$374000.0 in Q4 2025.

Profusa (PFSA) has 3 years of Share-based Compensation data on file, last reported at $187000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Share-based Compensation rose 3640.0% year-over-year to $187000.0; the trailing twelve-month figure through Mar 2026 stood at $435000.0 (changed N/A YoY), and the FY2025 full-year result was $330000.0, up 1471.43% from the prior year.
  • Share-based Compensation for Q1 2026 stood at $187000.0, up from -$374000.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $617000.0 in Q3 2025 and bottomed at -$374000.0 in Q4 2025.
  • The 3-year median for Share-based Compensation is $8500.0 (2024), against an average of $75333.3.
  • Peak annual rise in Share-based Compensation reached 5041.67% in 2025, while the deepest fall reached 7580.0% in 2025.
  • A 3-year view of Share-based Compensation shows it stood at $5000.0 in 2024, then tumbled by 7580.0% to -$374000.0 in 2025, then jumped by 150.0% to $187000.0 in 2026.
  • The last three Share-based Compensation figures came in at $187000.0 (Q1 2026), -$374000.0 (Q4 2025), and $617000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 317.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 87.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 94.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 83.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 45.40 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 43.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 35.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 12.90 Mn
10 Profusa 574,294.01 574,294.01 - 187,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 187,000.00
Mar 31, 2026 187,000.00
Dec 31, 2025 -374,000.00
Dec 31, 2025 -374,000.00
Sep 30, 2025 617,000.00
Sep 30, 2025 617,000.00
Dec 31, 2024 5,000.00
Dec 31, 2024 5,000.00
Sep 30, 2024 12,000.00
Sep 30, 2024 12,000.00